{"article_title": "Apax Expands Software Portfolio with Thoma Bravo&#8217;s InfoVista", "article_keywords": ["bravo8217s", "recently", "target", "bravo", "solarwinds", "stake", "buy", "apax", "thoma", "portfolio", "infovista", "expands", "software"], "article_url": "http://www.themiddlemarket.com/news/tech_telecom/apax-expands-software-portfolio-with-thoma-bravos-infovista-260195-1.html", "article_text": "Apax Expands Software Portfolio with Thoma Bravo\u2019s InfoVista\n\nThoma Bravo recently invested in SolarWinds and MedeAnalytics\n\nApax Partners has agreed to buy software company InfoVista SA from Thoma Bravo. Financial terms were not disclosed. Paris-based InfoVista provides network performance management software to communication service companies, mobile operators and government organizations. The target has more than 1,500 customers.\n\n\u201cAt the time of our acquisition, we worked closely with them on an aggressive growth plan that built upon the successful platform they had developed,\u201d says Thoma Bravo partner Robert Sayle. Thoma Bravo acquired InfoVista in 2012 and under Thoma Bravo's ownership, InfoVista has made at least two add-on deals including Mentum (2012) and Ipanema Technologies (2015).\n\nThoma Bravo, based in Chicago, recently closed a $1 billion fund that will target lower middle market software companies. In 2015, the firm partnered with Silver Lake to buy SolarWinds and also closed a deal for MedeAnalytics. Thoma Bravo won Mergers & Acquisitions 2014 M&A Mid-Market Deal of the Year award for its $930 million acquisition of TravelClick.\n\nLondon-based Apax has ample experience in the technology space. Some of its investments include Aptos and Exact Software. The PE firm has also been active in other sectors lately. Earlier in 2016, Apax said it will buy a majority stake in the respiratory business of Becton, Dickinson and Co. (NYSE: BDX) and in 2015 it purchased a stake in weight loss services provider Ideal Protein.\n\nFor more information on related topics, visit the following:", "article_metadata": {"status": "open", "domain": "Mergers & Acquisitions", "sailthru.author": "Demitri Diakantonis", "sailthru.expire_date": "2016-04-24 06:00:00", "og": {"url": "http://www.themiddlemarket.com/news/tech_telecom/apax-expands-software-portfolio-with-thoma-bravos-infovista-260195-1.html", "image": "http://cdn.themiddlemarket.com/media/newspics/datacables.jpeg", "site_name": "Mergers & Acquisitions, Latest News", "title": "Apax Expands Software Portfolio with Thoma Bravo\u2019s InfoVista"}, "type": "Article", "brand": "Mergers & Acquisitions, Latest News", "sailthru.date": "2016-03-24 06:00:00", "wordcount": 211, "sailthru.title": "Apax Expands Software Portfolio with Thoma Bravo\u2019s InfoVista", "featured": 0, "sailthru.tags": "News, Private Equity, Business Services, Tech, Media & Telecom, Tech, Media & Telecom, Apax Expands Software Portfolio with Thoma Bravo s InfoVista, private equity, technology, business services, MedeAnalytics, SolaWinds, software, Aptos, Exact Software, Beckton Dickinson, Ideal Protein, Mentum, Ipanema Technologies, Article", "sailthru.description": "Thoma Bravo recently invested in SolarWinds and MedeAnalytics", "sailthru.image.full": "http://cdn.themiddlemarket.com/media/newspics/datacables.jpeg"}, "_id": "\"57477af46914bd0286fe0597\"", "article_summary": "Apax Expands Software Portfolio with Thoma Bravo\u2019s InfoVistaThoma Bravo recently invested in SolarWinds and MedeAnalyticsApax Partners has agreed to buy software company InfoVista SA from Thoma Bravo.\nThoma Bravo acquired InfoVista in 2012 and under Thoma Bravo's ownership, InfoVista has made at least two add-on deals including Mentum (2012) and Ipanema Technologies (2015).\nThoma Bravo won Mergers & Acquisitions 2014 M&A Mid-Market Deal of the Year award for its $930 million acquisition of TravelClick.\nThoma Bravo, based in Chicago, recently closed a $1 billion fund that will target lower middle market software companies.\nIn 2015, the firm partnered with Silver Lake to buy SolarWinds and also closed a deal for MedeAnalytics."}